[
  {
    "filename": "van_Rijn_2022_Fibrosis_MAGNIFI-CD.pdf",
    "extraction_timestamp": "2024-10-22T10:30:00Z",
    "paper_title": "Fibrosis and MAGNIFI-CD Activity Index at Magnetic Resonance Imaging to Predict Treatment Outcome in Perianal Fistulizing Crohn\u2019s Disease Patients",
    "publication_year": 2022,
    "study_type": "Retrospective cohort study",
    "n_patients": 50,
    "has_paired_vai_magnificd_scores": false,
    "paired_scores": [],
    "vai_summary": null,
    "magnificd_summary": {
      "pre_treatment_median": 16,
      "pre_treatment_iqr": "9-20",
      "pre_treatment_closed_median": 11,
      "pre_treatment_closed_iqr": "7-18",
      "pre_treatment_open_median": 19,
      "pre_treatment_open_iqr": "15-23",
      "post_treatment_closed_median": 0,
      "post_treatment_closed_iqr": "0-5",
      "post_treatment_open_median": 16,
      "post_treatment_open_iqr": "10-20",
      "post_treatment_anti_tnf_closed_median": 5,
      "post_treatment_anti_tnf_closed_iqr": "3-5",
      "post_treatment_surgical_closed_median": 0,
      "post_treatment_surgical_closed_iqr": "0-2",
      "post_treatment_anti_tnf_open_median": 16,
      "post_treatment_anti_tnf_open_iqr": "9-18",
      "post_treatment_surgical_open_median": 18,
      "post_treatment_surgical_open_iqr": "16-20",
      "range": "0-25"
    },
    "fibrosis_summary": {
      "pre_treatment_less_than_40_percent": 38,
      "pre_treatment_less_than_40_percent_percentage": 79,
      "post_treatment_100_percent_fibrotic_n": 14,
      "post_treatment_100_percent_fibrotic_closed_n": 14,
      "post_treatment_0_percent_fibrotic_open_n": "All",
      "post_treatment_60_percent_fibrotic_anti_tnf_closed_percentage": 67,
      "post_treatment_60_percent_fibrotic_surgical_closed_percentage": 100
    },
    "correlations": [
      {
        "system_a": "MAGNIFI-CD index",
        "system_b": "Long-term clinical closure",
        "correlation_coefficient": null,
        "correlation_type": "ROC AUC",
        "p_value": null,
        "confidence_interval": "0.89-1.00",
        "n_patients": 46,
        "context": "Predictive accuracy for long-term clinical closure"
      },
      {
        "system_a": "Degree of fibrosis",
        "system_b": "Long-term clinical closure",
        "correlation_coefficient": null,
        "correlation_type": "ROC AUC",
        "p_value": null,
        "confidence_interval": "0.82-0.99",
        "n_patients": 50,
        "context": "Predictive accuracy for long-term clinical closure"
      }
    ],
    "vai_magnificd_correlation": null,
    "scatterplots": [
      {
        "figure_reference": "Figure 5",
        "x_axis": "MAGNIFI-CD index",
        "y_axis": "Long-term clinical closure status (open/closed)",
        "n_datapoints": 46,
        "correlation_shown": null,
        "regression_line": null,
        "estimated_points": [
          {
            "description": "Closed fistulas clustered at low MAGNIFI-CD scores (median 0, IQR 0-5)",
            "x_range": "0-5",
            "y_value": "Closed"
          },
          {
            "description": "Open fistulas clustered at higher MAGNIFI-CD scores (median 16, IQR 10-20)"
          }
        ]
      },
      {
        "figure_reference": "Figure 3",
        "x_axis": "Degree of fibrosis (100% to 0%)",
        "y_axis": "Long-term clinical closure status (open/closed)",
        "n_datapoints": 50,
        "correlation_shown": null,
        "regression_line": null,
        "estimated_points": [
          {
            "description": "100% fibrosis: all points in 'closed' category",
            "x_value": "100%",
            "y_value": "Closed"
          },
          {
            "description": "0% fibrosis: all points in 'open' category",
            "x_value": "0%",
            "y_value": "Open"
          }
        ]
      }
    ],
    "tables_with_scores": [
      {
        "table_reference": "Table 1",
        "columns": [
          "Item",
          "Scoring options",
          "MAGNIFI-CD Weight"
        ],
        "has_vai": false,
        "has_magnificd": true,
        "has_fibrosis": true,
        "row_summaries": [
          "Degree of fibrosis: 100%, 80\u201399%, 60\u201379%, 40\u201359%, 20\u201339%, 1\u201319%, 0%",
          "Number of tracts: 0=None, 1=Single unbranched, 2=Complex (Weight=3)",
          "Hyperintensity on post-contrast T1-weighted images: 0=Absent/mild, 1=Pronounced (Weight=2)",
          "Dominant feature: 0=Fibrous, 1=Granulation tissue, 2=Fluid/pus",
          "Fistula length: 0=<2.5 cm, 1=2.5\u20135 cm, 2=>5 cm (Weight=2)",
          "Extension: 0=Absent, 1=Horseshoe, 2=Infralevatoric/supralevatoric (Weight=2)",
          "Inflammatory mass: 0=Absent, 1=Focal, 2=Diffuse, 3=Collections small, 4=Collections medium, 5=Collections large (Weight=1)",
          "Total MAGNIFI-CD Range: 0-25"
        ]
      },
      {
        "table_reference": "Table 2",
        "columns": [
          "Total n=50",
          "N [%] or median [IQR]"
        ],
        "has_vai": false,
        "has_magnificd": true,
        "has_fibrosis": true,
        "row_summaries": [
          "Pre-treatment MRI characteristics [n=48]",
          "Degree of fibrosis <40%: 38 [79%]",
          "MAGNIFI-CD: 16 [9\u201320]"
        ]
      },
      {
        "table_reference": "Table 3",
        "columns": [
          "Item",
          "\u03ba or ICC [95% CI]"
        ],
        "has_vai": false,
        "has_magnificd": true,
        "has_fibrosis": true,
        "row_summaries": [
          "Degree of fibrosis: 0.77 [0.64\u20130.89]",
          "MAGNIFI-CD index: 0.88 [0.79\u20130.93]"
        ]
      }
    ],
    "component_mappings": [
      {
        "vai_component": null,
        "magnificd_component": "Number of tracts",
        "relationship": null,
        "notes": "MAGNIFI-CD component: 0=None, 1=Single unbranched, 2=Complex (Weight=3)"
      },
      {
        "vai_component": "T2 hyperintensity",
        "magnificd_component": "Hyperintensity on post-contrast T1-weighted images",
        "relationship": "Similar concept (inflammation)",
        "notes": "VAI includes T2 hyperintensity; MAGNIFI-CD includes hyperintensity on post-contrast T1 (Weight=2)"
      },
      {
        "vai_component": "Collection/abscess",
        "magnificd_component": "Inflammatory mass",
        "relationship": "Similar concept",
        "notes": "Both assess presence of abscess/inflammatory collections"
      },
      {
        "vai_component": "Rectal wall involvement",
        "magnificd_component": "Extension",
        "relationship": "Similar concept (extent)",
        "notes": "MAGNIFI-CD extension includes infralevatoric/supralevatoric extension"
      }
    ],
    "vai_components_described": [
      "T2 hyperintensity",
      "Collection/abscess",
      "Rectal wall involvement"
    ],
    "magnificd_components_described": [
      "Degree of fibrosis",
      "Number of tracts",
      "Hyperintensity on post-contrast T1-weighted images",
      "Dominant feature",
      "Fistula length",
      "Extension",
      "Inflammatory mass"
    ],
    "fibrosis_definition": "Fibrosis was defined as an absence of hyperintensity on all sequences.",
    "fibrosis_scoring_method": "The item degree of fibrosis was composed for the current study... It was evaluated by estimating the volume of the fistula tract that consisted of fibrosis on a T2-weighted sequence without fat suppression... No actual fistula volumes were measured.",
    "conversion_statements": [],
    "extraction_confidence": 0.85,
    "key_findings": [
      "The study evaluates MAGNIFI-CD index and a novel 'degree of fibrosis' score (0-100%) for predicting long-term clinical closure.",
      "No direct comparison or crosswalk between Van Assche Index (VAI) and MAGNIFI-CD is provided.",
      "The MAGNIFI-CD index at post-treatment MRI had high accuracy (AUC 0.95) for predicting long-term closure.",
      "A cut-off point of MAGNIFI-CD index \u22646 predicts long-term clinical closure with 91% specificity and 87% sensitivity.",
      "A completely fibrotic tract (100% fibrosis) at post-treatment MRI was associated with long-term clinical closure in all 14 patients.",
      "The degree of fibrosis (0-100%) had an AUC of 0.90 for predicting long-term closure.",
      "Interobserver agreement for the MAGNIFI-CD index was 'almost perfect' (ICC 0.88).",
      "The study includes separate analyses for anti-TNF and surgical closure treatment groups."
    ],
    "limitations": [
      "No direct paired VAI and MAGNIFI-CD scores are reported.",
      "The study focuses on MAGNIFI-CD and a novel fibrosis score, not on VAI.",
      "The sample size is relatively small (n=50).",
      "Partially retrospective design with different intervals between treatment and post-treatment MRI."
    ],
    "raw_evidence": [
      "This study evaluated the predictive value of degree of fibrosis and disease activity (MAGNIFI-CD index) at MRI for long-term clinical closure of Crohn\u2019s perianal fistulas.",
      "Two radiologists scored the degree of fibrosis and MAGNIFI-CD index at pre- and post-treatment MRI.",
      "Median MAGNIFI-CD index at post-treatment MRI was 0 [IQR 0\u20135] in 25 patients with long-term clinical closure and 16 [IQR 10-20] in 25 patients without.",
      "ROC analysis shows an AUC of 0.95 [95% CI: 0.89\u20131.00] accuracy in predicting long-term clinical closure. The Youden threshold to determine long-term clinical closure was a MAGNIFI-CD index of 6, with a 91% specificity and 87% sensitivity.",
      "All 14 patients who had a 100% fibrotic fistula at their post-treatment MRI showed long-term clinical closure.",
      "The median pre-treatment MAGNIFI-CD index was 11 [IQR 7\u201318] in patients who reached long-term clinical closure after their treatment and 19 [IQR 15\u201323] in patients who did not.",
      "The MAGNIFI-CD index in the anti-TNF group with a closed fistula at long-term clinical follow-up had a median of 5 [IQR 3\u20135], while in the surgical closure group this was 0 [IQR 0\u20132].",
      "For the MAGNIFI-CD index as a whole this was \u2018almost perfect\u2019 [ICC 0.88].",
      "The item degree of fibrosis was composed for the current study to gain insight into the effect of a partially fibrotic tract on long-term outcomes and has not been evaluated previously.",
      "Fibrosis was defined as an absence of hyperintensity on all sequences.",
      "Table 1 shows the scoring items and calculation of the MAGNIFI-CD index.",
      "The degree of fibrosis was assessed on all 50 scans [28 anti-TNF and 22 surgical closure] and the MAGNIFI-CD index on the 46 scans [25 anti-TNF and 21 surgical closure] which had a post-contrast sequence."
    ]
  },
  {
    "filename": "Radiological_Outcomes_Systematic_Review_2020.pdf",
    "extraction_timestamp": "2024-10-22T12:00:00Z",
    "paper_title": "Radiological outcomes in perianal fistulizing Crohn\u2019s disease: A systematic review and meta-analysis",
    "publication_year": 2020,
    "study_type": "systematic review and meta-analysis",
    "n_patients": 259,
    "has_paired_vai_magnificd_scores": false,
    "paired_scores": [],
    "vai_summary": null,
    "magnificd_summary": null,
    "fibrosis_summary": null,
    "correlations": [],
    "vai_magnificd_correlation": null,
    "scatterplots": [],
    "tables_with_scores": [
      {
        "table_reference": "Table 1",
        "columns": [
          "Study and year of publication",
          "Number of pfCD patients",
          "Gender",
          "Mean/median age (years)",
          "Induction therapy",
          "Maintenance therapy"
        ],
        "has_vai": false,
        "has_magnificd": false,
        "has_fibrosis": false,
        "row_summaries": [
          "Bell et al. (2003): 7 patients, 3M/4F, age 39, 7 infliximab induction, no maintenance",
          "Van Assche et al. (2003): two-part study, 8 patients then 7 patients, infliximab",
          "Tougeron et al. (2009): 26 patients, infliximab",
          "Ng et al. (2009): 26 patients, 10M/16F, 19 infliximab/7 adalimumab",
          "Savoye-Collet et al. (2011): 20 patients, 6M/14F, age 34, 10 infliximab/10 adalimumab",
          "Karmiris et al. (2011): 59 patients, 22M/37F, age 23, all infliximab",
          "Horsthius et al. (2011): 16 patients, 9M/7F, age 34, 16 infliximab induction, no maintenance",
          "Tozer et al. (2012): 41 patients, 16M/25F, age 36, 32 infliximab/9 adalimumab induction, 25 infliximab/16 adalimumab maintenance",
          "Thomassin et al. (2017): 49 patients, 28M/21F, age 33, 43 infliximab/6 adalimumab"
        ]
      },
      {
        "table_reference": "Table 2",
        "columns": [
          "Study",
          "Follow-up time (median or mean)",
          "Clinical, n (%) Remission",
          "Clinical, n (%) Response",
          "Clinical, n (%) No response",
          "Radiological, n (%) Healing",
          "Radiological, n (%) Improved",
          "Radiological, n (%) No response",
          "Odds ratio, 95% CI"
        ],
        "has_vai": false,
        "has_magnificd": false,
        "has_fibrosis": false,
        "row_summaries": [
          "Van Assche et al. (2003) part 1: 6 weeks clinical/MRI, 4/8 remission, 1/8 response, 3/8 no response, 0/8 healing, 2/8 improved, 6/8 no response, OR 0.030 (0.00-0.56)",
          "Van Assche et al. (2003) part 2: 10 weeks clinical/MRI, 4/7 remission, 2/7 response, 1/7 no response, 0/7 healing, 6/7 improved, 1/7 no response",
          "Tougeron et al. (2009): 8-12 weeks clinical, 13/26 remission",
          "Karmiris et al. (2011): 11 weeks MRI, 3/29 healing",
          "Horsthius et al. (2011): 12 weeks clinical/MRI, 6/16 remission, 1/16 response, 9/16 no response, 1/16 healing, OR 0.17 (0.030-0.90)"
        ]
      },
      {
        "table_reference": "Table 3",
        "columns": [
          "Study",
          "Follow up time (median or mean)",
          "Clinical, n (%) Remission",
          "Clinical, n (%) Response",
          "Clinical, n (%) No response",
          "Radiological, n (%) Healing",
          "Radiological, n (%) Improved",
          "Radiological, n (%) No response",
          "Odds ratio, 95 CI"
        ],
        "has_vai": false,
        "has_magnificd": false,
        "has_fibrosis": false,
        "row_summaries": [
          "Bell et al. (2003): 14 weeks, 4/7 remission, 1/7 response, 2/7 no response, 2/7 healing, 3/7 improved, 2/7 no response, OR 0.30 (0.030-2.76)",
          "Van Assche et al. (2003): 46 weeks MRI, 2/6 healing, 1/7 improved, 3/6 no response",
          "Tougeron et al. (2009): 255 weeks clinical, 74 weeks MRI, 11/16 remission, 2/14 healing, OR 0.45 (0.050-4.21)",
          "Ng et al. (2009): 52 weeks clinical, 72 weeks MRI, 12/26 remission, 13/26 response, 1/26 no response, 6/20 healing, 13/20 improved, 1/20 no response, OR 0.50 (0.15-1.71)",
          "Savoye-Collet et al. (2011): 52 weeks, 7/20 remission, 8/20 response, 5/20 no response, 2/20 healing, 15/20 improved, 3/20 no response, OR 0.21 (0.040-1.16)",
          "Karmiris et al. (2011): 36 weeks clinical, 94.5 weeks MRI, 24/59 remission, 21/59 response, 14/59 no response, 1/13 healing, OR 0.12 (0.010-1.00)",
          "Tozer et al. (2012): 156 weeks, 4/19 remission, 7/19 response, 7/19 no response, 6/19 healing, 4/19 improved, 9/19 no response, OR 1.73 (0.40-7.51)",
          "Thomassin et al. (2017): 160 weeks clinical, >104 weeks MRI, 26/49 remission, 10/49 response, 13/49 no response, 16/49 healing, OR 0.43 (0.19-0.96)"
        ]
      }
    ],
    "component_mappings": [],
    "vai_components_described": [
      "number of tracts",
      "location",
      "presence/absence of levatoric extension",
      "degree of T2 hyperintensity",
      "presence/absence of collections",
      "rectal wall involvement"
    ],
    "magnificd_components_described": [],
    "fibrosis_definition": null,
    "fibrosis_scoring_method": null,
    "conversion_statements": [
      "A universally accepted grading system for pfCD is therefore yet to be developed."
    ],
    "extraction_confidence": 0.8,
    "key_findings": [
      "This is a systematic review of 9 studies (259 patients) reporting MRI outcomes in perianal fistulizing Crohn's disease treated with anti-TNF\u03b1 therapy.",
      "The van Assche score was assessed in seven papers, with conflicting findings.",
      "There remains conflicting data regarding the significance of the van Assche score, particularly in real-world studies, as seen in our review.",
      "No direct mention of MAGNIFI-CD scoring system found in this paper.",
      "The paper discusses heterogeneity in definitions of radiological and clinical outcomes.",
      "The odds ratio of MRI healing versus clinical healing was 0.10 (95% CI, 0.02-0.39) in the short term and 0.43 (95% CI, 0.26-0.71) in the long term."
    ],
    "limitations": [
      "No direct comparison between VAI and MAGNIFI-CD found.",
      "No paired patient scores for both indices found.",
      "No correlation coefficients between scoring systems reported.",
      "No scatterplots showing VAI vs MAGNIFI-CD found.",
      "No fibrosis scoring data found.",
      "No patient-level data tables found."
    ],
    "raw_evidence": [
      "Composite scores, such as the van Assche score, have been proposed, incorporating anatomical (number of tracts, location, presence/absence of levatoric extension) and inflammatory features (degree of T2 hyperintensity, presence/absence of collections, rectal wall involvement) as a marker of disease severity.",
      "The van Assche score was assessed in seven papers, with conflicting findings.",
      "There remains conflicting data regarding the significance of the van Assche score, particularly in real-world studies, as seen in our review.",
      "A universally accepted grading system for pfCD is therefore yet to be developed.",
      "The odds ratio of MRI healing versus clinical in the short term was 0.10 (95% confidence interval [CI], 0.02-0.39) and in the long term was 0.43 (95% CI, 0.26-0.71).",
      "Clinical healing is more common than radiological healing, by a factor of 10 in the short term and 2.33 in the long term."
    ]
  },
  {
    "filename": "MRI_Role_Review_2018.pdf",
    "extraction_timestamp": "2025-12-03T00:00:00Z",
    "paper_title": null,
    "publication_year": null,
    "study_type": null,
    "n_patients": null,
    "has_paired_vai_magnificd_scores": false,
    "paired_scores": [],
    "vai_summary": null,
    "magnificd_summary": null,
    "fibrosis_summary": null,
    "correlations": [],
    "vai_magnificd_correlation": null,
    "scatterplots": [],
    "tables_with_scores": [],
    "component_mappings": [],
    "vai_components_described": [],
    "magnificd_components_described": [],
    "fibrosis_definition": null,
    "fibrosis_scoring_method": null,
    "conversion_statements": [],
    "extraction_confidence": 0.1,
    "key_findings": [
      "The provided content is the homepage of the journal 'Insights into Imaging', not a research paper.",
      "No research article content, tables, figures, or data related to perianal Crohn's disease, MRI scoring systems, Van Assche Index (VAI), or MAGNIFI-CD was found."
    ],
    "limitations": [
      "The input is a journal homepage, not a research paper. It contains general journal information, metrics, and article listings, but no specific study data.",
      "No extraction of paired scores, correlations, component mappings, or fibrosis data was possible.",
      "The filename 'MRI_Role_Review_2018.pdf' suggests a review paper, but the content provided does not match."
    ],
    "raw_evidence": [
      "The provided text is from the SpringerOpen website for the journal 'Insights into Imaging'.",
      "It includes journal description: 'Insights into Imaging focuses on practices and new techniques applied to all areas of clinical radiology...'",
      "It lists 'Latest articles' on various topics (azoospermia, thyroid carcinoma, nasopharyngeal carcinoma, uterine fibroids) unrelated to perianal Crohn's disease.",
      "No mention of Van Assche Index, MAGNIFI-CD, perianal fistula, or Crohn's disease.",
      "No tables, figures, or data sections are present in the provided text."
    ]
  }
]